Clinical Trial Update: Simvastatin Addition for Patients With Recent-onset Schizophrenia [Phase 3]

View source ↗

Summary

Phase 3 trial assessing the addition of simvastatin in patients with recent-onset schizophrenia; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psychosis Nos
• Schizoaffective Disorder
• Schizophrenia
• Schizophreniform Disorder

Drugs mentioned

• SIMVASTATIN (SIMVASTATIN)

Snippet

Sponsor: Iris Sommer | Conditions: Schizophrenia, Schizoaffective Disorder | Phase 3 | Status: COMPLETED